RITAMIX(01936.HK)中期純利582.9萬令吉 同比增加106.12%
格隆匯8月30日丨RITAMIX(01936.HK)公佈,截至2021年6月30日止6個月,公司實現收益5677.2萬令吉,同比減少3.07%;公司權益持有人應占期內溢利582.9萬令吉,同比增加106.12%;每股盈利1.17令吉仙。
製造業務所得收益減少乃主要由於期內向海外客户銷售的維生素預混料減少約3.7百萬令吉。董事認為,由於大流行造成的持續高海運成本及海運時間表的不確定性,相較於本地供應,自馬來西亞進口的競爭力已相對較低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.